25th BioPharma Clinical Trials Nexus Conference 2026. In Zurich (29-30 April 2026)

We had insightful discussions at our exhibiting booth and met fellow innovators. Our CEO, Dr. Deepa Arora, also participated in the panel discussion on “Strategic Outsourcing in Clinical Development: Lessons from Big Pharma for Emerging Biotechs.”

The session highlighted the contrasting outsourcing approaches, while large pharma retains key strategic functions, emerging biotech and smaller companies often rely on outsourcing for most clinical development activities.

At CLINEXEL, we work closely with emerging biotechs and pharma companies, taking leadership across clinical trial execution with minimal sponsor oversight. By leveraging deep big pharma experience, we also support effective risk mitigation and bring added value to ensure successful trial outcomes.

Our CSO, Dr Mukesh Kumar, was a part of the roundtable discussion: “Collaboration at the Front Line: How Pharma, Biotech, CROs & Sites Can Advance Inclusive Trials Together.”

He shared perspectives on how thoughtful trial design can go beyond compliance, integrate regulatory expectations, improve inclusiveness, and address risk mitigation. Using real-world experience, the discussion highlighted how emerging biotechs can navigate complexity and build efficient, patient-centric clinical development programs.